Deutsche Bank AG Lowers Holdings in Inspire Medical Systems (INSP)

Deutsche Bank AG trimmed its stake in Inspire Medical Systems (NASDAQ:INSP) by 60.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,478 shares of the company’s stock after selling 23,829 shares during the period. Deutsche Bank AG’s holdings in Inspire Medical Systems were worth $653,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the business. Geode Capital Management LLC lifted its position in Inspire Medical Systems by 65.7% during the fourth quarter. Geode Capital Management LLC now owns 134,286 shares of the company’s stock valued at $5,673,000 after acquiring an additional 53,223 shares during the last quarter. Dimensional Fund Advisors LP purchased a new stake in Inspire Medical Systems during the fourth quarter valued at approximately $2,359,000. Millennium Management LLC lifted its position in Inspire Medical Systems by 326.5% during the fourth quarter. Millennium Management LLC now owns 273,079 shares of the company’s stock valued at $11,538,000 after acquiring an additional 209,048 shares during the last quarter. Cetera Advisors LLC purchased a new stake in Inspire Medical Systems during the fourth quarter valued at approximately $207,000. Finally, Capital Financial Planning LLC purchased a new stake in Inspire Medical Systems during the fourth quarter valued at approximately $27,000.

In other news, Director Marilyn C. Nelson sold 152,985 shares of Inspire Medical Systems stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $51.66, for a total transaction of $7,903,205.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Richard Buchholz sold 2,000 shares of Inspire Medical Systems stock in a transaction on Wednesday, February 20th. The stock was sold at an average price of $56.87, for a total transaction of $113,740.00. The disclosure for this sale can be found here. Insiders have sold 293,074 shares of company stock valued at $15,527,150 over the last quarter.

NASDAQ:INSP opened at $51.93 on Friday. Inspire Medical Systems has a 52 week low of $27.30 and a 52 week high of $64.34.

Inspire Medical Systems (NASDAQ:INSP) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.39) by $0.04. The company had revenue of $16.30 million for the quarter, compared to analyst estimates of $17.79 million. The business’s revenue for the quarter was up 63.0% on a year-over-year basis.

A number of research firms recently commented on INSP. Zacks Investment Research cut shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research report on Saturday, May 11th. Dougherty & Co began coverage on shares of Inspire Medical Systems in a research report on Tuesday, February 5th. They set a “buy” rating and a $64.00 target price for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. Inspire Medical Systems currently has an average rating of “Hold” and an average target price of $43.56.

WARNING: This story was originally published by WKRB News and is owned by of WKRB News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.wkrb13.com/2019/05/19/deutsche-bank-ag-lowers-holdings-in-inspire-medical-systems-insp.html.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Featured Article: Closed-End Mutual Funds

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems (NASDAQ:INSP).

Institutional Ownership by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.